shortagewatch

Home / Respiratory system / Roflumilast

ATC R03DX07 · Other Systemic Drugs for Obstructive Airway Diseases

Roflumilast shortage

As of 2 Nov 2026, Roflumilast has a reported shortage in 1 of the 16 countries we track (Czechia), covering 2 products from 1 company.

Countries1/16
Products2packs or presentations
Companies11 listed
Short since30 Jun 20264 months ago
Earliest return18 Dec 2026company estimate
Main reasonManufacturing problem
United StatesNo reported shortageCanadaNo reported shortageGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechia2 products shortNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageNew ZealandNo reported shortageAustraliaNo reported shortage

Timeline

Czechia
2027RUMIXAFEN 500MCG 500MCG TBL FLM 90RUMIXAFEN 500MCG 500MCG TBL FLM 90RUMIXAFEN 500MCG 500MCG TBL FLM 30RUMIXAFEN 500MCG 500MCG TBL FLM 30today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Sandoz2 SDZ

Listed: Sandoz SDZ · SIX Swiss

Compared with similar medicines

ATC group R03DX · Other Systemic Drugs for Obstructive Airway Diseases
Omalizumab4/16Mepolizumab2/16Benralizumab1/16Roflumilast1/16Tezepelumab1/16

Affected products

CountryProductCompanySinceExpected backReason
CZRUMIXAFEN 500MCG 500MCG TBL FLM 90Sandoz s.r.o., Praha30 Jun 202622 Jan 2027Manufacturing problem
Výrobní důvody
CZRUMIXAFEN 500MCG 500MCG TBL FLM 30Sandoz s.r.o., Praha22 Sep 202618 Dec 2026Distribution or logistics
Kapacitní/distribuční důvody

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.